Related Experiment Videos
Lymphoid proliferations in the orbit: malignant or benign?
The British Journal of Ophthalmology
|December 1, 1984
Summary
Distinguishing benign from malignant ocular adnexal lymphoid disease requires surgical intervention. Immunological techniques improve diagnosis of orbital lymphoid infiltrates, aiding treatment.
Area of Science:
- Ophthalmology
- Oncology
- Immunology
Background:
- Ocular adnexal lymphoid diseases encompass a spectrum from benign reactive hyperplasia to malignant non-Hodgkin lymphoma (NHL).
- Accurate differentiation is crucial for appropriate patient management and prognosis.
Observation:
- Patients in their 40s-50s with acute symptoms (pain, swelling, double vision) and a lacrimal gland mass may present with pseudolymphoma or chronic inflammation rather than NHL.
- Surgical intervention is often necessary for definitive diagnosis, as peripheral blood markers for monoclonal B cells were detected in only a minority of orbital NHL patients.
Findings:
- Clinical, pathological, and immunological analyses of 20 patients revealed key parameters for distinguishing benign from malignant lesions.
- Immunological techniques, when combined with clinical and histopathological methods, enhance the distinct identification of orbital lymphoid infiltrates.
Implications:
- Multidisciplinary collaboration improves the diagnosis and treatment of ocular adnexal lymphoproliferative diseases.
- Early and accurate diagnosis impacts treatment strategies and patient outcomes for lymphoid lesions in the eye socket.